Defining the Role of Trimetazidine in the Treatment of Cardiovascular Disorders: Some Insights on Its Role in Heart Failure and Peripheral Artery Disease
Why the study?
Does trimetazidine improve outcomes in patients with cardiovascular disorders such as heart failure and peripheral artery disease?
Population
Patients with cardiovascular disorders, including stable ischemic heart disease, chronic heart failure, and…
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Trimetazidine's net benefit remains uncertain amid efficacy controversies and Parkinsonian risks; leaves open need for updated RCTs.
Structured PICO
Does trimetazidine improve outcomes in patients with cardiovascular disorders such as heart failure and peripheral artery disease?
P
Population
Patients with cardiovascular disorders, including stable ischemic heart disease, chronic heart failure (with or without diabetes mellitus and arrhythmia), and peripheral artery disease
I
Intervention
Trimetazidine
This review summarizes the evidence and guidelines for trimetazidine in cardiovascular diseases, addressing the controversy between its cytoprotective benefits and side effects.
Cite This Study
Chruściel et al. (2014) studied this question.